Who we are

Owen Mumford specialises in integrated design and build services from a broad range of self-injection platform devices for the pharmaceutical industry.

From the first automatic lancing device to our patented self-injection devices, with Owen Mumford you have access to unrivalled experience in designing, developing and delivering solutions to help you make adherence easier for patients.


With more than 65 years’ experience, your device is in trusted hands with Owen Mumford.

From day one, we will guide you throughout the development process; at every step, you will benefit from professional and supportive project management, processes, industrialisation and production for a smooth development and launch.

The springless, passive safety device for pre-filled syringes

Fully designed, developed and ready for commercial supply

Comfort

Large, ergonomic plunger head and a smooth, integrated finger flange, resulting in an integrated look and feel.

Secure plunger

Plunger cannot detach when removing the RNS.

Reduced risk

No compromise to sterility in assembly – plunger does not touch the bung.

User confidence

Syringe barrel is unobscured, allowing the user to check the contents of the syringe, and to confirm the full dose has been delivered.

Reliability

Prevention of occidental activation e.g. in transit.

Simple 2-step final sembly

Final assembly process is simple and outside of the sterile filling area.

Cost effective

Designed to work with standard, pre-filled syringes which means no change to existing primary container and minimises training costs.

Passive safety

Passive needle retraction means that the device is safe as soon as the plunger is fully depressed

Self-Injection Device Solutions 

Ensuring that patients are willing and able to inject their medication is key to their well-being. As pioneers in self-injection technologies, our experience enables us to effectively work with you to find the right drug delivery solution.


Please visit: omdevicesolutions.com

Go to article: Home | Saving face: PR in pharma Go to article: In this issueGo to article: Emirates SkyCargoGo to article: ContentsGo to article: Hapa Company Insight Go to article: Owen MumfordGo to article: NewsGo to article: Dupont PharmaceuticalsGo to article: Accurate Biometrics Company Insight Go to article: Accurate BiometricsGo to article: The pharma industry briefingGo to article: Scandinavian Health Ltd.Go to article: Gerteis Company InsightGo to article: GerteisGo to article: Coughs and sneezes spread diseases: charting the development of flu vaccinesGo to article: Swiss WorldCargoGo to article: HOF Sonderanlagenbau Company Insight Go to article: HOF SonderanlagenbauGo to article: ‘Don’t put baby in the corner’: overcoming challenges in paediatric drug developmentGo to article: Qatar AirwaysGo to article: AtoZ-CRO Company InsightGo to article: AtoZ-CROGo to article: Debate: should countries bring critical drug production home?Go to article: AirBridgeCargo Company InsightGo to article: AirBridgeCargoGo to article: Capsugel Company Insight Go to article: Beyond Viagra Town: profiling the Irish pharma industryGo to article: Daiichi JitsugyoGo to article: TSS Company Insight Go to article: TSSGo to article: Recurrent miscarriage: could this devastating condition have a simple cure?Go to article: LB Bohle Company Insight Go to article: LB BohleGo to article: Public image limited: the role of PR in pharmaGo to article: Pharma Support Services Company InsightGo to article: Pharma Support ServicesGo to article: Q&A: Gavi alliance talks immunising 300 million people Go to article: Spirax Sarco Company Insight Go to article: Spirax SarcoGo to article: Bias remorse: are cancer drug trials clear enough on outcomes?Go to article: Zenatek Go to article: B&W TekGo to article: Deals in brief powered by GlobalDataGo to article: Centaur Clinical Insight Go to article: Centaur ClinicalGo to article: The key list powered by GlobalDataGo to article: AlpexGo to article: PfanstiehlGo to article: EventsGo to article: MimotopesGo to article: NymiGo to article: Next issue